Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.

MLA

Jensen, Lars H., et al. “Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors.” Cancer Research, vol. 65, no. 16, Aug. 2005, pp. 7470–77. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-05-0707.

APA

Jensen, L. H., Thougaard, A. V., Grauslund, M., Søkilde, B., Carstensen, E. V., Dvinge, H. K., Scudiero, D. A., Jensen, P. B., Shoemaker, R. H., & Sehested, M. (2005). Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors. Cancer Research, 65(16), 7470–7477. https://doi.org/10.1158/0008-5472.CAN-05-0707

Chicago

Jensen, Lars H, Annemette V Thougaard, Morten Grauslund, Birgitte Søkilde, Elisabeth V Carstensen, Henrik K Dvinge, Dominic A Scudiero, Peter B Jensen, Robert H Shoemaker, and Maxwell Sehested. 2005. “Substituted Purine Analogues Define a Novel Structural Class of Catalytic Topoisomerase II Inhibitors.” Cancer Research 65 (16): 7470–77. doi:10.1158/0008-5472.CAN-05-0707.